Group | Non-infection | Infection | p |
---|---|---|---|
n | 539 | 57 | Â |
Age (years) | 53 (48–59) | 54 (46–62) | 0.845 |
Sex (male) | 378 (70.1%) | 41 (71.9%) | 0.777 |
Body mass index (kg·m-2) | 24.2 (22.1–26.6) | 23.8 (21.3–25.7) | 0.181 |
Psoas muscle index (mm2·m-2) | 329.7 (261.0–401.4) | 295.7 (226.8–370.9) | 0.014 |
Etiology | Â | Â | 0.543 |
 Alcohol use | 127 (23.6%) | 10 (17.5%) |  |
 Hepatitis A | 21 (3.9%) | 4 (7.0%) |  |
 Hepatitis B | 292 (54.2%) | 29 (50.9%) |  |
 Hepatitis C | 33 (6.1%) | 6 (10.5%) |  |
 Autoimmune disorder | 23 (4.3%) | 4 (7.0%) |  |
 Drugs and toxins | 14 (2.6%) | 2 (3.5%) |  |
 Cryptogenic | 29 (5.4%) | 2 (3.5%) |  |
Comorbidity | |||
 Diabetes mellitus | 143 (26.5%) | 12 (21.1%) | 0.370 |
 Hypertension | 107 (19.9%) | 11 (19.3%) | 0.921 |
MELD score (points) | 15 (9–26) | 22 (13–35) | 0.001 |
CRRT | 67 (12.4%) | 15 (26.3%) | 0.004 |
Hepatocellular carcinoma | 240 (44.5%) | 19 (33.3%) | 0.105 |
 Beyond the Milan criteria | 24 (22.0%) | 1 (16.7%) | 1.000 |
Hepatic decompensation | |||
 Encephalopathy | 50 (9.3%) | 5 (8.8%) | 0.900 |
 Varix | 132 (24.5%) | 12 (21.1%) | 0.564 |
 Ascites | 248 (46.0%) | 33 (57.9%) | 0.087 |
Cardiac function | |||
 Ejection fraction (%) | 64.6 (62.0–67.0) | 64.6 (63.5–67.0) | 0.174 |
 Diastolic dysfunction | 230 (42.7%) | 25 (43.9%) | 0.863 |
Laboratory variables | |||
 Hemoglobin (g·dL-1) | 9.8 (8.4–11.6) | 9.2 (8.1–11.1) | 0.243 |
 WBC count (×109·L-1) | 4.4 (2.8–7.3) | 4.4 (2.7–9.6) | 0.689 |
 C-reactive protein to albumin ratio | 0.14 (0.04–0.54) | 0.25 (0.07–0.88) | 0.003 |
  C-reactive protein (mg·dL-1) | 0.4 (0.1–1.5) | 0.8 (0.2–2.3) | 0.005 |
  Albumin (g·dL-1) | 3.0 (2.6–3.4) | 2.8 (2.6–3.4) | 0.058 |
 Neutrophil to lymphocyte ratio | 2.80 (1.67–6.03) | 3.99 (2.31–10.28) | 0.002 |
  Neutrophils (×109·L-1) | 2.5 (1.5–5.0) | 2.8 (1.7–6.8) | 0.131 |
  Lymphocytes (×109·L-1) | 0.9 (0.6–1.4) | 0.8 (0.4–1.2) | 0.031 |
 Platelet to lymphocyte ratio | 76.09 (53.09–112.09) | 81.27 (54.22–115.38) | 0.583 |
  Platelet count (×109·L-1) | 63.0 (45.0–102.0) | 57.0 (37.5–86.0) | 0.060 |
 Sodium (mEq·L-1) | 139 (135–142) | 138 (134–141) | 0.117 |
 Potassium (mEq·L-1) | 4.0 (3.7–4.3) | 3.9 (3.6–4.5) | 0.832 |
 Total bilirubin (mg·dL-1) | 2.5 (0.9–13.4) | 2.8 (0.9–28.6) | 0.204 |
 International normalized ratio | 1.5 (1.2–2.1) | 1.5 (1.3–2.0) | 0.777 |
 Creatinine (mg·dL-1) | 0.8 (0.7–1.2) | 1.0 (0.7–2.0) | 0.025 |
 Glucose (mg·dL-1) | 109 (92 –139) | 113 (95–143) | 0.555 |